GlassScriptPhysician profile
Stephanie L Fields
NPI 1518307560
$11,433.80
in general payments reported to CMS, 2019-2025
33 companies · $2,600 in 2025
The $2,600 reported for 2025 was more than what 97% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,773 · 2022: $1,799 · 2023: $2,719 · 2024: $2,543 · 2025: $2,600.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,763 · Education: $98.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,763.06 |
| Education | $98.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $2,103.36 | 2021-2025 | Trelegy Ellipta, Nucala, Arexvy |
| Astrazeneca Pharmaceuticals LP | $1,789.17 | 2021-2025 | Fasenra, Airsupra, Tezspire |
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,762.97 | 2021-2025 | Ofev, Stiolto Respimat, Spiriva Respimat |
| Grifols USA, LLC | $959.31 | 2021-2025 | Prolastin-C Liquid |
| Genzyme Corporation | $704.63 | 2021-2025 | |
| Regeneron Healthcare Solutions, INC. | $647.73 | 2021-2025 | Dupixent |
| Takeda Pharmaceuticals U.S.A., INC. | $525.96 | 2021-2025 | Glassia, Aralast |
| Insmed, INC. | $387.28 | 2021-2025 | Arikayce, Brinsupri |
| Amgen INC. | $356.00 | 2022-2025 | Tezspire |
| Electromed, INC. | $348.90 | 2021-2025 | Smartvest |
| Mylan Specialty L.P. | $288.72 | 2021-2024 | Yupelri |
| Actelion Pharmaceuticals US, INC. | $249.16 | 2021-2023 | Uptravi, Opsumit |
| Inogen, INC. | $173.05 | 2022-2024 | Inogen One G5 Oxygen Concentrator - Bluetooth |
| Viatris Specialty LLC | $151.33 | 2025 | Yupelri |
| Harmony Biosciences LLC | $133.83 | 2023-2024 | Wakix |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Philips North America LLC | $131.76 | 2022-2025 | (Ak6) Vest Therapy, Vest Therapy Und |
| Genentech USA, INC. | $110.26 | 2021-2024 | Xolair |
| Verona Pharma, INC. | $105.44 | 2025 | Ohtuvayre |
| Mallinckrodt Hospital Products INC. | $93.93 | 2022-2025 | Acthar |
| Jazz Pharmaceuticals INC. | $68.19 | 2024-2025 | |
| United Therapeutics Corporation | $45.48 | 2024-2025 | Tyvaso, Tyvaso |
| Merck Sharp & Dohme LLC | $45.07 | 2022-2024 | Verquvo |
| Novartis Pharmaceuticals Corporation | $38.02 | 2025 | |
| Boston Scientific Corporation | $34.69 | 2025 | Bodyguardian, Cds - Mct/Cem Monitoring |
| Lexicon Pharmaceuticals, INC. | $30.53 | 2023 | Inpefa |
| Avadel Cns Pharmaceuticals, LLC | $27.14 | 2024 | Lumryz |
| Baxter Healthcare | $23.14 | 2024 | Hillrom - Vest System Model 105 Home Care |
| Medtronic, INC. | $20.16 | 2025 | |
| Pfizer INC. | $18.57 | 2023 | |
| Paratek Pharmaceuticals, INC. | $16.70 | 2025 | Nuzyra |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $14.75 | 2024 | Lifevest |
| Lilly USA, LLC | $14.34 | 2025 | Mounjaro |
| Fisher & Paykel Healthcare INC | $14.23 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephanie Fields listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.